| __timestamp | Blueprint Medicines Corporation | Ligand Pharmaceuticals Incorporated |
|---|---|---|
| Wednesday, January 1, 2014 | 7890000 | 22570000 |
| Thursday, January 1, 2015 | 14456000 | 24378000 |
| Friday, January 1, 2016 | 19218000 | 26621000 |
| Sunday, January 1, 2017 | 27986000 | 28653000 |
| Monday, January 1, 2018 | 47928000 | 37734000 |
| Tuesday, January 1, 2019 | 96388000 | 41884000 |
| Wednesday, January 1, 2020 | 157743000 | 64435000 |
| Friday, January 1, 2021 | 195293000 | 57483000 |
| Saturday, January 1, 2022 | 237374000 | 70062000 |
| Sunday, January 1, 2023 | 295141000 | 52790000 |
| Monday, January 1, 2024 | 359272000 |
Unleashing insights
In the competitive world of biotechnology, managing expenses is crucial for sustaining growth and innovation. This analysis compares the Selling, General, and Administrative (SG&A) expenses of Blueprint Medicines Corporation and Ligand Pharmaceuticals Incorporated from 2014 to 2023. Over this period, Blueprint Medicines has seen a staggering increase in SG&A expenses, growing by approximately 3,640%, from $7.89 million in 2014 to $295 million in 2023. In contrast, Ligand Pharmaceuticals experienced a more modest increase of about 134%, from $22.57 million to $52.79 million.
Understanding these trends provides valuable insights into each company's strategic priorities and market positioning.
Who Optimizes SG&A Costs Better? AbbVie Inc. or Blueprint Medicines Corporation
Bristol-Myers Squibb Company and Blueprint Medicines Corporation: SG&A Spending Patterns Compared
Comparing SG&A Expenses: Regeneron Pharmaceuticals, Inc. vs Blueprint Medicines Corporation Trends and Insights
Comparing SG&A Expenses: Takeda Pharmaceutical Company Limited vs Ligand Pharmaceuticals Incorporated Trends and Insights
SG&A Efficiency Analysis: Comparing Blueprint Medicines Corporation and PTC Therapeutics, Inc.
Blueprint Medicines Corporation and Bausch Health Companies Inc.: SG&A Spending Patterns Compared
Blueprint Medicines Corporation vs Taro Pharmaceutical Industries Ltd.: SG&A Expense Trends
Operational Costs Compared: SG&A Analysis of Viking Therapeutics, Inc. and Ligand Pharmaceuticals Incorporated
Who Optimizes SG&A Costs Better? Xenon Pharmaceuticals Inc. or Ligand Pharmaceuticals Incorporated
Breaking Down SG&A Expenses: Merus N.V. vs Ligand Pharmaceuticals Incorporated
Who Optimizes SG&A Costs Better? Ligand Pharmaceuticals Incorporated or Galapagos NV